Mad Money

Cramer's lightning round: BioXcel Therapeutics is good for a spec play

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

BioXcel Therapeutics: "It's got all the great buzz words. It's biopharma, it's artificial intelligence, and the reason why I'm going to say that it's OK is because it can be your own speculation. I'm willing everyone to have everyone have one speculation. That can be yours."

Schrodinger: "No, I have not liked this company. I don't really get the attraction to it. ... It's just not a great company. ... They can come on and tell me otherwise."

Dada Nexus: "I am recommending Alibaba. I'm actually saying buy Alibaba aggressively, but that's about all I want to do with China. I mean, I think JD's pretty good too, but that's enough for me in the midst of a trade war."

HCA Healthcare: "There has just been tremendous turmoil. It's very expensive to run a hospital right now and they're not going to get any breaks, I think, from either party. So, I don't want to yet as you go into the election."

ADT: "I don't like that company. I don't think it's run very well. I think there's a lot of other companies offering those services."

Five9: "It is the best contact call center. We've had them on a number of times. Everytime I'm impressed. Everytime I know that they do tremendous value. I can't believe that they're actually not taken over by someone because it does work with a lot of other comapnies that need contact cloud centers."

Cramer's lightning round: BioXcel Therapeutics is good for a spec play
VIDEO4:0904:09
Cramer's lightning round: BioXcel Therapeutics is good for a spec play

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com